Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07318077 · ClinicalTrials.gov registry record · NA
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
A NA study of GI Health and Belly Pain, sponsored by Radicle Science.
- Recruiting
- Registry status
- NA
- Development phase
- 825
- Enrollment target
- 1
- Study location
NCT07318077: Recruiting NA study of GI Health and Belly Pain, sponsored by Radicle Science.
NCT07318077 is a NA study of GI Health and Belly Pain that is actively recruiting participants, run by Radicle Science. The registered enrollment target is 825 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07318077, a NA study of GI Health and Belly Pain, is actively recruiting participants, sponsored by Radicle Science.
- RECRUITING
- Registry status
- NA
- Development phase
- 825 participants
- Enrollment target
- 1
- Study location
Study Summary
Radicle GI Health DBG: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.
Primary Outcome
Change in Belly Pain: Difference between rates of change over time in belly pain score as assessed by PROMIS Belly Pain 5A (scale 2-25; where the higher scores correspond to worse belly pain)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT GI Health Product Placebo Control
- DIETARY_SUPPLEMENT GI Health Active Product 1
- DIETARY_SUPPLEMENT GI Health Active Product 2
Study Locations (1)
California
- Radicle Science Inc. - Del Mar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 825 participants |
| Start Date | 2026-01-06 |
| Est. Completion | 2027-01-13 |
| Phase | NA |
What NCT07318077 shows while recruiting
NCT07318077 is an interventional study that assigns participants to a tested intervention. The registered 825 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 2 conditions, with GI Health appearing as the primary indexed condition, and to 3 interventions - of which GI Health Product Placebo Control is the first listed.
NCT07318077 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07318077 about?
NCT07318077 is a clinical study titled "Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes". Radicle GI Health DBG: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI health and related health outcomes.
What is the current status of trial NCT07318077?
This trial is currently recruiting. It is a NA study. The enrollment target is 825 participants. The study started on 2026-01-06. Estimated completion is 2027-01-13.
What conditions does trial NCT07318077 study?
This clinical trial studies the following conditions: GI Health, Belly Pain.
What interventions are being tested in trial NCT07318077?
The interventions under investigation include: GI Health Product Placebo Control (DIETARY_SUPPLEMENT), GI Health Active Product 1 (DIETARY_SUPPLEMENT), GI Health Active Product 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07318077?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07318077 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GI Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07318077's enrollment target sits among peer trials
825 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
- NCT06944509 · 824 participants · NA
RADIQAL Study (Radiation Dose and Image Quality Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI